EyeYon Medical


EyeYon Medical is a pioneering company in ophthalmologic medical devices, dedicated to developing innovative solutions for corneal health. Their mission is to heal corneas and preserve the vision of millions of patients worldwide through advanced technologies like EndoArt® and Hyper-CL™.

EyeYon Medical Logo

EyeYon Medical

3 Golda Meir St., 6th floor, Ness Ziona 7403648 Israel


Patents

Treatment to improve adhesive properties of corneal implant

2024-02-20 • US-11903877-B2

View Details

Corneal implant with peripheral skirt

2024-02-06 • US-11890183-B2

View Details

Endothelial ocular implant

2023-08-29 • US-11737919-B2

View Details

Corneal implant injector system

2023-06-20 • US-11678973-B2

View Details

Contact lens drug depot

2021-08-03 • US-11079613-B2

View Details

Treatment to improve adhesive properties of corneal implant

2021-06-08 • US-11026839-B2

View Details

What We Do

EndoArt® is the first synthetic implant designed to treat corneal edema, providing a new solution for corneal transplants and preserving vision.

Hyper-CL™ is a therapeutic contact lens that acts as a drug depot, increasing the bioavailability of topical drops for treating various corneal conditions.



Key People

CEO, Co-founder

LinkedIn

Medical Director, Co-founder


News & Updates

EyeYon Medical will be attending the 40th Congress of the ESCRS in Milan, showcasing their contributions to the event.

EyeYon Medical was featured in the media following the first EndoArt surgery in England, highlighting the positive impact on the patient's vision.

This publication discusses the successful treatment of neurotrophic keratopathy using Hyper-CL and insulin eye drops.

EndoArt received the Breakthrough Device Designation from the FDA, marking a significant milestone in its development.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.